BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Shire Pharmaceuticals Group plc 

Hampshire International Business Park
Chineham
Basingstoke  Hampshire  RG24 8EP  United Kingdom
Phone: 44-1256-894-000 Fax: 44-1256-894-708


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Shire (SHPGY) May Spend AbbVie (ABBV) Breakup Fee On NPS Pharmaceuticals, Inc. (NPSP); NPS Surges On Rumor 12/18/2014 5:52:29 AM
Shire Pharmaceuticals Group plc (SHPGY) To Participate At The Credit Suisse 2014 Global Healthcare Conference 11/6/2014 10:31:17 AM
The Reason Why Shire Is Moving Its HQ From Ireland To The U.K. 10/10/2014 6:37:10 AM
Shire Pharmaceuticals Group plc (SHPGY) Provides Regulatory Update On SHP 465, Investigational Compound For ADHD In Adults 10/9/2014 9:38:51 AM
Shire plc Release: Management Spurns Three Offers From AbbVie (ABBV) , Fighting For Irish Independence, Call Monday Morning 6/23/2014 12:42:43 PM
Shire Pharmaceuticals Group plc (SHPGY) To Host Investor Call 6/23/2014 7:00:26 AM
Shire Pharmaceuticals Group plc (SHPGY) Agrees To FDA Request To Conduct Clinical Trials Investigating The Potential Use of Vyvanse® (lisdexamfetamine dimesylate) In Preschool-Age Children With ADHD 6/12/2014 7:40:01 AM
Shire plc Release:” New Phase 3 Data For Guanfacine Extended Release (GXR) To Be Presented At European Congress Of Psychiatry 2/27/2014 8:30:05 AM
Shire Pharmaceuticals Group plc (SHPGY) Published Study Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII Provided Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD 8/5/2010 10:34:50 AM
Shire Pharmaceuticals Group plc (SHPGY) Initiates Two Adult ADHD Outreach Programs 8/17/2009 8:32:47 AM
12345678910...